Breast cancer patients in Poland face further delays as reimbursement for genetic testing remains pending.
Reimbursement Status
The Polish healthcare system has not yet approved reimbursement for multi-gene testing for breast cancer patients, requiring them to wait longer for access.
Patient Impact
This delay means critically ill breast cancer patients continue to face uncertainty regarding timely access to advanced genetic testing crucial for treatment decisions.
